Apeloa Pharmaceutical Co.,Ltd
000739
Κατάταξη σε μετοχές
#4311
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Τιμή μετοχής
$3.17
Κεφαλαιοποίηση
$3.67B
Αλλαγή (1 ημέρα)
0.76%
Αλλαγή (1 έτος)
40.57%
Χώρα
CN
Εμπόριο Apeloa Pharmaceutical Co.,Ltd (000739)
Κατηγορία
Healthcare
EPS για Apeloa Pharmaceutical Co.,Ltd (000739)
EPS στις June 2026 TTM: $0.11
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Apeloa Pharmaceutical Co.,Ltd, το τρέχον EPS της εταιρείας (TTM) είναι $0.11. Στο τέλος του 2023, η εταιρεία είχε EPS $0.13, αύξηση σε σχέση με το EPS του 2022 που ήταν $0.12.
Ιστορικό EPS της Apeloa Pharmaceutical Co.,Ltd από 2000 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2024 | $0.12 | -4.09% |
| 2023 | $0.13 | 3.17% |
| 2022 | $0.12 | -3.30% |
| 2021 | $0.13 | 20.64% |
| 2020 | $0.11 | 56.44% |
| 2019 | $0.07 | 47.70% |
| 2018 | $0.05 | 35.21% |
| 2017 | $0.03 | 2.11% |
| 2016 | $0.03 | 19.49% |
| 2015 | $0.03 | -42.77% |
| 2014 | $0.05 | 39.88% |
| 2013 | $0.03 | -22.94% |
| 2012 | $0.04 | 265.04% |
| 2011 | $0.01 | 136.54% |
| 2010 | $0.01 | -30.67% |
| 2009 | $0.01 | 17.19% |
| 2008 | $0.01 | -3.03% |
| 2007 | $0.01 | -45.00% |
| 2006 | $0.01 | 57.89% |
| 2005 | $0.01 | 24.59% |
| 2004 | $0.01 | 5.17% |
| 2003 | $0.01 | 7.41% |
| 2002 | $0.01 | -210.20% |
| 2001 | 0.00 | 716.67% |
| 2000 | 0.00 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
